Diets, Foods and Food Components Effect on Dyslipidemia
Dyslipidemia, and particularly hypercholesterolemia, remains a main cardiovascular disease risk factor, partly reversible with the improvement of life-style, including dietary, habits. Even when a pharmacological treatment is begun, dietary support to lipid-lowering is always desired. This book will...
| Format: | eBook |
|---|---|
| Language: | English |
| Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Subjects: | |
| Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
| LEADER | 04852namaa2201477uu 4500 | ||
|---|---|---|---|
| 001 | doab76758 | ||
| 003 | oapen | ||
| 005 | 20220111 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 220111s2021 xx |||||o ||| 0|eng d | ||
| 020 | |a 9783036512389 | ||
| 020 | |a 9783036512396 | ||
| 020 | |a books978-3-0365-1239-6 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-1239-6 |2 doi | |
| 040 | |a oapen |c oapen | ||
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MBN |2 bicssc | |
| 720 | 1 | |a Fogacci, Federica |4 edt | |
| 720 | 1 | |a Borghi, Claudio |4 edt | |
| 720 | 1 | |a Borghi, Claudio |4 oth | |
| 720 | 1 | |a Cicero, Arrigo |4 edt | |
| 720 | 1 | |a Cicero, Arrigo |4 oth | |
| 720 | 1 | |a Fogacci, Federica |4 oth | |
| 245 | 0 | 0 | |a Diets, Foods and Food Components Effect on Dyslipidemia |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 online resource (300 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
| 520 | |a Dyslipidemia, and particularly hypercholesterolemia, remains a main cardiovascular disease risk factor, partly reversible with the improvement of life-style, including dietary, habits. Even when a pharmacological treatment is begun, dietary support to lipid-lowering is always desired. This book will provide a selection of new evidence on the possible lipid-lowering effects of some dietary and medicinal plant components, reporting some interesting reviews, experimental data and results from clinical trials. The book is adapted for experts in nutrition but also for all scientists involved in cardiovascular disease prevention. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Public health and preventive medicine |2 bicssc | |
| 653 | |a alpha-linolenic acid | ||
| 653 | |a animal based | ||
| 653 | |a Armolipid Plus® | ||
| 653 | |a berberine | ||
| 653 | |a bergamot | ||
| 653 | |a beta-glucan | ||
| 653 | |a black raspberry | ||
| 653 | |a blackcurrant | ||
| 653 | |a blood pressure | ||
| 653 | |a cardiovascular health | ||
| 653 | |a Chinese adults | ||
| 653 | |a chitosan | ||
| 653 | |a CHNS | ||
| 653 | |a cholesterol | ||
| 653 | |a Chrysanthemum morifolium Ramat leaves | ||
| 653 | |a clinical trial | ||
| 653 | |a CVD | ||
| 653 | |a dietary factor | ||
| 653 | |a dietary fats | ||
| 653 | |a dietary fiber | ||
| 653 | |a dietary intake | ||
| 653 | |a dietary pattern | ||
| 653 | |a dyslipidemia | ||
| 653 | |a endothelial function | ||
| 653 | |a epigallocatechin gallate | ||
| 653 | |a Eudragit | ||
| 653 | |a excessive choline | ||
| 653 | |a fasting plasma glucose | ||
| 653 | |a fiber | ||
| 653 | |a flaxseed | ||
| 653 | |a formononetin | ||
| 653 | |a gastric ulcer | ||
| 653 | |a glibenclamide | ||
| 653 | |a green tea | ||
| 653 | |a healthy | ||
| 653 | |a hepatic inflammation | ||
| 653 | |a high fat diet | ||
| 653 | |a HNF1α | ||
| 653 | |a hypercholesterolemia | ||
| 653 | |a intestinal function | ||
| 653 | |a LCD score | ||
| 653 | |a LDL-cholesterol | ||
| 653 | |a lifestyle | ||
| 653 | |a lipid profile | ||
| 653 | |a lipidomics | ||
| 653 | |a lipids | ||
| 653 | |a liquid chromatography tandem mass spectrometry | ||
| 653 | |a liver steatosis | ||
| 653 | |a metabolic diseases | ||
| 653 | |a metabolic syndrome | ||
| 653 | |a microspheres | ||
| 653 | |a monacolins | ||
| 653 | |a n/a | ||
| 653 | |a natural antioxidant | ||
| 653 | |a nutraceutical | ||
| 653 | |a nutraceuticals | ||
| 653 | |a obesity | ||
| 653 | |a omega-3 | ||
| 653 | |a omega-3 fatty acids | ||
| 653 | |a ovariectomized | ||
| 653 | |a PCSK9 | ||
| 653 | |a phospholipid | ||
| 653 | |a phytoestrogen | ||
| 653 | |a phytosterols | ||
| 653 | |a plant based | ||
| 653 | |a plant extracts | ||
| 653 | |a plant-based diet | ||
| 653 | |a polyphenols | ||
| 653 | |a propolis | ||
| 653 | |a rats | ||
| 653 | |a red yeast rice | ||
| 653 | |a review | ||
| 653 | |a Saudi Arabia | ||
| 653 | |a serum cholesterol | ||
| 653 | |a serum high density lipoprotein | ||
| 653 | |a serum low density lipoprotein | ||
| 653 | |a serum triglycerides | ||
| 653 | |a sphingolipid | ||
| 653 | |a SREBP | ||
| 653 | |a streptozotocin | ||
| 653 | |a supplementation | ||
| 653 | |a sustainability | ||
| 653 | |a TMAO | ||
| 653 | |a transcription factors | ||
| 653 | |a type 2 diabetes mellitus | ||
| 653 | |a vitamin B12 | ||
| 653 | |a walnuts | ||
| 793 | 0 | |a DOAB Library. | |
| 856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/76758 |7 0 |z Open Access: DOAB: description of the publication |
| 856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/4207 |7 0 |z Open Access: DOAB, download the publication |